The COVID-19 pandemic has highlighted vulnerabilities within the generic drug supply chain. To minimize the effects of antibiotic API supply disruptions, it is important to understand the underlying reasons for shortages to then identify the best-fit manufacturing partners. The COVID-19 pandemic has disrupted the global drug supply, as manufacturing companies contend with government-mandated or […]